ReviewPolymers2025
Biobased Polyamides: A Journey from the Biomass Towards Cutting Edge Materials.
Review in Polymers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- A Green Approach Towards Desalination: Sustainable Poly(lactic acid) Membranes for Pervaporation Desalination.Membranes · 2026Review
- Microbial and Enzymatic Degradation of Nylon: Mechanisms, Diversity, and Biotechnological Application.Journal of microbiology and biotechnology · 2026Review
- Eugenol and Chavicol-Based Polyamides from Synthesis to Degradation: Moving Towards Closing the Circle.Polymers · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Since the 1930s, polyamides (PAs) have become increasingly vital across industries like automotive, textiles, electronics, and packaging, owing to their exceptional properties. However, they also have notable limitations, including a tendency to absorb water, low dimensional stability, poor solubility, and the resulting processing challenges. From an environmental perspective, the reliance on fossil-based monomers for traditional PAs and the accumulation of post-consumer waste, due to their resistance to (bio)degradation, are key concerns. In recent decades, significant advancements have been made in synthesizing PAs from bio-based monomers, primarily sourced from inedible lignocellulosic materials. Some of these bio-based PAs exhibit properties comparable to their fossil-derived counterparts, with benefits like enhanced solubility, which simplifies processing. Moreover, certain bio-based variants have shown improved biodegradability, facilitating the potential recovery of monomers for the production of new virgin polymers and reducing waste accumulation. This review highlights the progress in developing PAs from commonly used bio-based sources, including lignin-derived aromatic compounds, terpenes, fatty acids, and furan derivatives, with a focus on the improvements made over their fossil-based analogs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.